Cargando…
Eculizumab: A Review in Generalized Myasthenia Gravis
The humanized monoclonal antibody eculizumab (Soliris(®)) is a complement inhibitor indicated for use in anti-acetylcholine receptor (AChR) antibody-positive adults with generalized myasthenia gravis (gMG) in the USA, refractory gMG in the EU, or gMG with symptoms that are difficult to control with...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845078/ https://www.ncbi.nlm.nih.gov/pubmed/29435915 http://dx.doi.org/10.1007/s40265-018-0875-9 |